Health
Early statin use after type 2 diabetes diagnosis linked to lower dementia risk, study finds
An observational study of over 130,000 Danish patients indicates that initiating cholesterol-lowering drugs within a year of diagnosis is associated with reduced dementia rates.
The short version
- A large observational study of Danish health records found that starting statin therapy within one year of a type 2 diabetes diagnosis is associated with a 15% lower relative risk of dementia over a decade.
- Delaying statin initiation between one and five years post-diagnosis was still associated with a 10% lower relative risk.
- Experts emphasize that because the study is observational, it shows correlation rather than direct causation, though it supports evaluating statin therapy earlier in routine diabetes management.
Key facts
- The study analyzed health records from 132,585 people in Denmark diagnosed with type 2 diabetes between 2006 and 2019 who had no prior history of statin use or dementia.[Fox News]
- Over a median follow-up period of 7.1 years, individuals starting statins within a year of diagnosis had a 15% lower relative risk of dementia over 10 years compared to those who did not take statins within five years.[Fox News]
- The findings were presented at the European Society of Cardiology Congress in Munich and published in The Lancet Regional Health – Europe.[Fox News]
- According to geriatrician Dr. Liron Sinvani, the observed reduction in risk was primarily driven by lower rates of vascular dementia rather than Alzheimer's disease.[Fox News]
What remains uncertain
- Because the study design was observational rather than a randomized clinical trial, it cannot establish a direct causal link between statin use and dementia prevention.[Fox News]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.